CWE-287

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

ABB eSOMS version 6.0.2 may allow unauthorized access to the system when LDAP is set to allow anonymous authentication, and specific key values within the eSOMS web.config file are present. Both conditions are required to exploit this vulnerability.

In Drobo 5N2 4.0.5, all optional applications lack any form of authentication/authorization validation. As a result, any user capable of accessing the device over the network may interact with and control these applications. This not only poses a severe risk to the availability of these applications, but also poses severe risks to the confidentiality and integrity of data stored within the applications and the device itself.

An insecure transport protocol used by Drobo Dashboard API on Drobo 5N2 NAS version 4.0.5-13.28.96115 allows attackers to intercept network traffic.

Incorrect access control in the Dashboard API on Drobo 5N2 NAS version 4.0.5-13.28.96115 allows attackers to bypass authentication due to insecure token generation.

The SAML broker consumer endpoint in Keycloak before version 4.6.0.Final ignores expiration conditions on SAML assertions. An attacker can exploit this vulnerability to perform a replay attack.